Krajina: Rakúsko
Jazyk: angličtina
Zdroj: HMA (Heads of Medicines Agencies)
oxantel embonate 500.7 mg, praziquantel 125 mg, pyrantel embonate 124.85 mg
Vetoquinol
QP52AA51
Tablet
praziquantel, combinations
Dogs
2011-05-19
VETOQUINOL/DOLPAC LARGE DOGS/ EUROPEAN RENEWAL JUNE 2011 1/5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Austria Belgium Cyprus Malta Czech Republic Netherlands Greece Portugal Slovakia Hungary Slovenia Germany Finland Dolpac large dogs tablets France Luxembourg Dolpac 25 comprimé UK-Ireland-Italy Dolpac Tablets for Large Dogs Poland Spain Dolpac large dogs tablets for 20-75 kg Denmark Sweden Dolpac vet large dogs tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains : Active substances Oxantel 500.70 mg (equivalent to 1397.5 mg of oxantel embonate) Pyrantel 124.85 mg (equivalent to 360 mg of pyrantel embonate) Praziquantel 125.00 mg Excipient to one 2375 mg divisible tablet Excipients For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Tablet Pale yellow to yellow oblong tablet with breaking line. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For curative treatment of dogs harbouring mixed parasitic infestations with t he following adult stages of nematode and cestode species: Nematodes: _ _ _ _ _Toxocara canis_ _ _ _ _ _Toxascaris leonina _ _ _ _ _ _Ancylostoma caninum_ _ _ _ _ _Uncinaria stenocephala _ _ _ _ _ _Trichuris vulpis_ VETOQUINOL/DOLPAC LARGE DOGS/ EUROPEAN RENEWAL JUNE 2011 2/5 Cestodes: _ _ _ _ _Dipylidium caninum _ _ _ _ _ _Taenia _spp _ _ _ _ _Echinococcus multilocularis_ _ _ _ _ _Echinococcus granulosus_ 4.3 CONTRAINDICATIONS See section 4.8 4. Prečítajte si celý dokument